(MENAFN - Khaleej Times) Question: I lost my tooth and tooth bone due to a medical error of a dentist in a Dubai clinic. The clinic staff acknowledged the error (verbally) but refused to do anything about it. I registered a case with the Dubai Health Authority (DHA) and have got a report in my favour, stating it was a medical malpractice that caused me immense physical and mental trauma. I want to report this case in the Press for the larger good of people, so that no one suffers like me. But the hospital says it will sue me if I do so. Can I publish this case in the media with the DHA report or will I get sued?
Cuba reporta 888 nuevos casos de COVID-19, cuatro fallecidos cubadebate.cu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cubadebate.cu Daily Mail and Mail on Sunday newspapers.
FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression
Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer. Cosela may help protect bone marrow cells from damage caused by chemotherapy by inhibiting cyclin- dependent kinase 4/6, a type of enzyme.
For patients with extensive-stage small cell lung cancer, protecting bone marrow function may help make their chemotherapy safer and allow them to complete their course of treatment on time and according to plan. Today s approval of Cosela will give patients a treatment option that can reduce the occurrence of a common, harmful side effect of chemotherapy.
Ministerio de Salud Pública: Cuba reporta 888 nuevos casos de COVID-19 para un acumulado de 37 483 (+Video) › Información del Minsap › Granma granma.cu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from granma.cu Daily Mail and Mail on Sunday newspapers.
Scientists conduct interdisciplinary study on using nanoparticles to fight leukemia
Scientists from Scientific and Educational Center & Smart Materials and Biomedical Applications under the leadership of Kateryna Levada together with colleagues from Center for Immunology and Cellular Biotechnology of the Immanuel Kant Baltic Federal University conducted a joint interdisciplinary study on the development of a new method for treating leukemia using nanomaterials.
The scientists analyzed how magnetic nanoparticles can be manipulated in in vitro conditions to achieve a selective antitumor effect. The method is based on the combined action of nanoparticles and permanent magnetic fields on human tumor cells.
Leukemia (lymphoblastic leukemia) is the most common type of blood cancer in children and adolescents. This cancer affects the bone marrow and leads to the degradation of the human immune system. It accounts for 75-80% of acute leukemias, which also affect adults. Current methods of